tinoridine
Small moleculeexperimental
Clinical trial activity
1 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
1
Earliest trial started Nov 1, 2010 (NCT01224756)
Timeline
No events for the selected filters.
Indications
Approved for
Studied for
Mechanism of action
- CyclooxygenaseINHIBITOR
Cyclooxygenase inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
CCOC(=O)c1c(N)sc2c1CCN(Cc1ccccc1)C2- Mol. weight
- 316.43 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL592943 ↗
Also known as
- 2-amino-6-benzyl-4,5,6,7-tetrahydrothieno(2,3-c)-pyridine-3-carboxylic acid ethyl ester
- nonflamin
- nonflamine
- tienoridine
- tienoridine hcl
- tienoridine hydrochloride
- tinoridin
- tinoridine
- tinoridine
- tinoridine
- tinoridine
- tinoridine
- tinoridine
- tinoridine
- tinoridine hcl
- tinoridine hcl
- tinoridine hcl
- tinoridine hydrochloride
- tinoridine hydrochloride
- tinoridine hydrochloride
- tinoridine hydrochloride
- tinoridine hydrochloride
- tinoridine monohydrochloride
- y 3642
- y-3642
- y-3642
- y-3642
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01224756 | Phase 4 | Nov 1, 2010 | Takeda |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Takeda | For profit | 1 | 1 | 1 | 2010 |
1 organizations
Page 1 / 1